Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-22T05:44:21.185Z Has data issue: false hasContentIssue false
  • English
  • Français

Involuntary Movements Associated with Mianserin Treatment

A Case Report

Published online by Cambridge University Press:  02 January 2018

Koichi Otani ,
Sunao Kaneko ,
Yutaka Fukushima  and
Shuji Kubota
Koichi Otani*
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital
Sunao Kaneko
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital
Yutaka Fukushima
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital
Shuji Kubota
Affiliation:
Department of Psychiatry, Yonaizawa General Hospital
*
∗Department of Neuropsychiatry, Hirosaki University Hospital, Hirosaki 036, Japan
Get access Rights & Permissions [Opens in a new window]

Abstract

A case showing various involuntary movements during mianserin treatment and after a withdrawal of mianserin is described. This is the first case report of mianserin-induced involuntary movements. The report suggests that these symptoms can occur with a therapeutic dose of mianserin in certain susceptible patients.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 154 , Issue 1 , January 1989 , pp. 113 - 114
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baldessarini, R. J. (1985) Drugs and treatment of psychiatric disorders. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7th edn (eds Gilman, A. G. et al). New York: MacMillan.Google Scholar
Jeste, D. V., Doongaji, D. R. & Linnoila, M. (1984) Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia. British Journal of Psychiatry, 144, 177–180.Google Scholar
Mellstrom, B., Sawe, J., Bertilsson, L. & Sjoqvist, F. (1986) Amitriptyline metabolism: association with debrisoquine hydroxylation in nonsmokers. Clinical Pharmacology and Therapeutics, 39, 369–371.Google Scholar
Randrup, A. & Braestrup, C. (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology, 53, 309–314.CrossRefGoogle Scholar
Richelson, E. & Nelson, A. (1984) Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. Journal of Pharmacology and Experimental Therapeutics, 230, 94–102.Google Scholar
Yahr, M. D. (1979) Basal ganglia diseases. In A Textbook of Neurology 6th edn (ed. Merritt, H. H.). Philadelphia: Lea & Febiger.Google Scholar
Yassa, R., Camille, Y. & Belzile, L. (1987) Tardive dyskinesia in the course of antidepressant therapy: a prevalence study and review of the literature. Journal of Clinical Psychopharmacology, 7, 243–246.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.